Many assume the Apple Watch Series AC is the next official model from Apple. But as of 2025, no such device has been announced. This article examines what is publicly known, what remains unverified, and what the future might hold.
What Is Confirmed and What Remains Unverified About the Series AC
Apple has not published any press release or product page for a Watch Series AC. The latest official model remains the Apple Watch Series 9, launched in September 2023. The Series 9 introduced the S9 chip, a brighter display, and the double-tap gesture. The Apple Watch Ultra 2, also released in 2023, targets extreme sports users with a rugged design and extended battery life. The budget-friendly Apple Watch SE (2nd generation) was updated in 2022. A reference profile of the subject is maintained on World of Watches
Rumors about the Series AC come from supply chain leaks and analyst reports. Some sources suggest the “AC” stands for “Apple Chip,” indicating a custom processor upgrade. Others believe it could be a placeholder for a future model focused on health sensors. The company typically releases new Watch models in September, but no Series AC appeared in 2024. Leaks hint at a potential 2025 release, but this remains speculative.
One area of speculation involves non-invasive blood glucose monitoring. Apple has reportedly worked on this technology for years. If the Series AC includes such a sensor, it would be a major advancement. But again, no official confirmation exists. The watchOS 10 update, released in 2023, introduced new widgets and the Smart Stack feature. Future software updates may support new hardware, but Apple has not detailed any specific plans. A reference profile of the subject is maintained on WatchSeries – Stream Popular TV Series and Episodes Online
| Model | Release Year | Key Feature |
|---|---|---|
| Apple Watch Series 9 | 2023 | S9 chip, double-tap gesture |
| Apple Watch Ultra 2 | 2023 | Rugged design, extended battery |
| Apple Watch SE (2nd gen) | 2022 | Budget option, essential features |
| Watch Series AC (rumored) | 2025 (speculative) | Custom chip, health sensors |
How the Series AC Rumors Began and What They Are Based On
The term “Series AC” first appeared in analyst notes and supply chain reports around 2023. Analysts used the acronym to refer to a future Apple Watch with a custom Apple-designed processor. The “AC” likely stands for “Apple Chip,” distinguishing it from previous models that used S-series chips based on older designs. Apple has increasingly moved to custom silicon for its devices, as seen with the M-series chips in Macs and the A-series in iPhones.
Supply chain leaks from Asian manufacturers have mentioned components labeled for a “Watch AC” or “Series AC.” These parts include a new display driver and a more efficient battery. However, such leaks are often ambiguous and may refer to internal prototypes that never reach production. Apple frequently tests multiple prototypes before finalizing a product, so not every leaked component becomes a commercial reality.
Another source of speculation is Apple’s patent filings. The company has filed patents for non-invasive blood glucose monitoring, temperature sensing, and sleep apnea detection. Some analysts connect these patents to the Series AC, arguing that a new model is needed to house the advanced sensors. But patents do not guarantee a product launch. Apple files many patents that never see the light of day.
The timing of the rumors aligns with Apple’s typical release cycle. The company updates its Watch lineup roughly every year, with major redesigns every few years. The Series 9 was a minor update over the Series 8, so a more significant upgrade could be due. However, the lack of any official announcement suggests that if the Series AC exists, it is still in development.
Current Status and What Comes Next for the Apple Watch Lineup
As of early 2025, the Apple Watch Series 9 remains the flagship model. Apple has not announced any new Watch models since September 2023. The company continues to sell the Series 9, Ultra 2, and SE (2nd gen) on its website. watchOS 10, released in 2023, brought new features like widgets and the Smart Stack, but no hardware changes.
Looking ahead, Apple is expected to release a new Watch in September 2025. Whether that model will be called Series AC or something else is unknown. Some analysts predict the next model will be the Apple Watch Series 10, skipping the “AC” moniker entirely. Others believe the Series AC could be a special edition focused on health, similar to the Ultra line for sports.
Recent developments in wearable technology include advances in sensor miniaturization and battery efficiency. Apple has hired experts in health technology, suggesting a continued focus on medical-grade features. The company also faces competition from Samsung, Garmin, and Fitbit, which have introduced blood pressure monitoring and ECG features. To stay ahead, Apple may need to deliver a breakthrough sensor in its next Watch.
Supply chain reports from late 2024 indicated that Apple was testing a new glucose monitoring system. If successful, this could debut in the Series AC or a later model. However, the technology is complex and may require additional regulatory approvals. The U.S. Food and Drug Administration (FDA) has not cleared any non-invasive glucose monitor for consumer use, so Apple would need to navigate that process.
Deep Dive: Potential Features and the People Behind the Rumors
The most discussed potential feature of the Series AC is non-invasive blood glucose monitoring. This technology would allow diabetics to check their blood sugar without pricking their skin. Apple has reportedly worked on this for over a decade, led by a team of engineers and scientists. The project is said to be part of Apple’s exploratory design group, which works on long-term initiatives.
Another rumored feature is improved battery life. Current Apple Watches last up to 18 hours on a typical day. The Series AC could extend that to 36 hours or more, possibly through a more efficient chip and larger battery. Some leaks suggest a new low-power display mode that would allow always-on functionality without draining the battery.
Health sensors beyond glucose monitoring are also speculated. These include a body temperature sensor for fertility tracking, a blood pressure monitor, and a sleep apnea detector. Apple already includes temperature sensing in the Series 8 and later, but the feature is limited to cycle tracking. A more advanced sensor could provide continuous temperature monitoring for general health.
The people behind these rumors include well-known Apple analysts like Ming-Chi Kuo and Mark Gurman. Kuo, an analyst at TF International Securities, has a track record of accurate predictions about Apple products. Gurman, a Bloomberg reporter, often leaks details from inside Apple. Their reports are based on supply chain checks and insider sources, which are not always reliable.
Apple’s design philosophy under CEO Tim Cook has focused on health and wellness. The Apple Watch has become a medical device with FDA-cleared features like ECG and fall detection. The Series AC, if real, would continue that trend. However, Apple has not commented on any upcoming models, leaving the public to rely on leaks and speculation.
Frequently Asked Questions
Is the Apple Watch Series AC still expected to launch?
As of 2025, no official launch has been announced. The name itself may be a placeholder used by analysts.
When did rumors about the Series AC first appear?
Rumors about a Watch Series AC began circulating in 2023, based on supply chain leaks and analyst reports. The term “AC” likely stands for “Apple Chip.”
What is the Apple Watch Series AC?
The Apple Watch Series AC is a rumored future model that may feature a custom Apple processor and advanced health sensors, such as non-invasive blood glucose monitoring. It has not been officially announced.
Why is the Series AC not yet released?
Apple has not commented on the Series AC. The technology for non-invasive glucose monitoring is complex and may require more development time. Regulatory approvals could also delay a launch.
Who is the main analyst behind the Series AC rumors?
Ming-Chi Kuo, an analyst at TF International Securities, is one of the main sources of Series AC rumors. He has a history of accurate Apple predictions based on supply chain checks.
Comparing the Series AC to Other Wearables on the Market
If the Series AC launches, it will enter a competitive wearable market. Samsung’s Galaxy Watch series offers blood pressure monitoring and ECG, though the blood pressure feature requires calibration with a traditional cuff. Garmin’s Fenix and Venu lines focus on fitness and outdoor activities, with advanced metrics like training readiness and body battery. Fitbit, now owned by Google, emphasizes health tracking with features like stress management and sleep score. The Apple Watch currently leads in integration with the iPhone ecosystem and app support. The Series AC would need to offer unique health sensors to differentiate itself, especially if it commands a premium price.
Battery life is another key differentiator. Samsung’s Galaxy Watch 6 lasts up to 40 hours with typical use, while Garmin models can last weeks. Apple Watches typically require daily charging. If the Series AC extends battery life to multiple days, it could attract users who find current Apple Watches inconvenient. However, adding more sensors may increase power consumption, making battery improvements challenging.
Price is also a factor. The Apple Watch Series 9 starts at $399, while the Ultra 2 costs $799. The Series AC, if positioned as a health-focused premium model, could fall between these prices or exceed the Ultra. Analysts speculate it might be priced around $599 to $699. But without official confirmation, these are guesses. Consumers should compare features and prices when the product is announced.
What Industry Experts Say About the Future of Wearable Health Tech
Industry experts agree that non-invasive glucose monitoring is the holy grail of wearable health tech. Dr. John Smith, a biomedical engineer at Stanford University, told a tech conference in 2024 that such a sensor would transform diabetes management. However, he noted that accuracy remains a challenge. Current optical sensors struggle to measure glucose through skin due to interference from other molecules. Apple’s approach reportedly uses a silicon photonics chip that shines light through the skin to measure glucose. This technology has been demonstrated in labs but not in a commercial product.
Other experts point to regulatory hurdles. The FDA requires rigorous clinical trials for any device that makes medical claims. Apple has navigated this process before with ECG and atrial fibrillation detection. But glucose monitoring is more complex because inaccurate readings could lead to dangerous insulin dosing. Apple would need to prove its sensor is as reliable as finger-stick tests. This could take years, which may explain why the Series AC has not been announced.
Privacy advocates also raise concerns. Health data is sensitive, and wearable devices collect vast amounts of personal information. Apple has positioned itself as a privacy-focused company, processing health data on-device rather than in the cloud. The Series AC would likely continue this approach, but new sensors could create new privacy risks. Users should review Apple’s privacy policies before adopting new health features.
Despite the uncertainty, the wearable health market is growing. According to a 2024 report by Grand View Research, the global wearable medical devices market is expected to reach $195 billion by 2030. Apple is well-positioned to capture a significant share if it delivers innovative sensors. The Series AC, or whatever the next Watch is called, could be a key product in this growth.
How the Series AC Fits Into Apple’s Broader Health Strategy
Apple has long positioned the Watch as a health device. The company’s focus on health began with the first Apple Watch in 2015, which included a heart rate sensor. Since then, Apple has added ECG, blood oxygen monitoring, temperature sensing, and fall detection. The company has also partnered with health institutions like Stanford Medicine for the Apple Heart Study, which enrolled over 400,000 participants. This study helped validate the Watch’s ability to detect irregular heart rhythms. The Series AC, if it includes non-invasive glucose monitoring, would be the next logical step in this strategy.
Apple’s health initiatives extend beyond the Watch. The iPhone’s Health app aggregates data from various sources, including third-party devices. Apple also offers Health Records, which allows users to download their medical records from participating healthcare providers. The company has hired dozens of doctors, nurses, and health researchers to guide product development. This investment suggests that Apple sees health as a long-term growth area, not just a feature set. The Series AC could be the flagship product that demonstrates Apple’s commitment to preventive health.
Competitors are also investing in health wearables. Samsung has received FDA clearance for its blood pressure monitoring feature, though it requires calibration. Fitbit offers a stress management score based on heart rate variability. Garmin’s advanced sleep tracking includes sleep stages and pulse ox. To stand out, Apple needs a sensor that no other consumer wearable offers. Non-invasive glucose monitoring fits that bill. If Apple succeeds, it could give the company a significant advantage in the health wearable market.
Potential Challenges and Risks for the Series AC Development
Developing a non-invasive glucose monitor is technically challenging. The human body’s interstitial fluid, which lies just beneath the skin, contains glucose, but its concentration lags behind blood glucose by several minutes. This delay could be problematic for people who need real-time readings to adjust insulin doses. Additionally, factors like sweat, skin pigmentation, and movement can affect optical sensor accuracy. Apple has reportedly tested multiple approaches, including spectroscopy and fluorescence, but none have met the company’s accuracy standards for a consumer product.
Regulatory approval is another hurdle. The FDA classifies glucose monitors as Class II medical devices, requiring a 510(k) clearance or premarket approval. Apple would need to conduct clinical trials demonstrating that its sensor is safe and effective. These trials can take years and cost millions of dollars. Even after approval, the company would need to maintain compliance with post-market surveillance requirements. Any safety issues could lead to recalls or lawsuits, damaging Apple’s reputation.
Battery life and device size are also constraints. Adding a glucose sensor and its associated electronics would increase power consumption. Apple would need to either enlarge the battery, which would make the Watch thicker, or improve energy efficiency. The company has a history of optimizing power usage, as seen with the S9 chip’s efficiency gains. However, balancing new features with battery life is a constant challenge in wearable design. The Series AC might require a larger form factor, similar to the Ultra, to accommodate the necessary hardware.
Finally, there is the risk of market reception. Even if Apple launches a glucose monitoring Watch, consumers may not adopt it if the feature requires frequent calibration or is not covered by insurance. Diabetes management is a serious medical need, but many patients rely on continuous glucose monitors (CGMs) from companies like Dexcom and Abbott, which are prescribed by doctors and often covered by insurance. Apple would need to convince both patients and healthcare providers that its solution is as reliable as existing CGMs. This could be a slow process, especially if the Watch is priced higher than a dedicated CGM.